SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-012142
Filing Date
2023-08-11
Accepted
2023-08-11 16:30:24
Documents
1
Period of Report
2023-08-10

Document Format Files

Seq Description Document Type Size
1 form4-08112023_040818.html 4  
1 form4-08112023_040818.xml 4 4061
  Complete submission text file 0001415889-23-012142.txt   5624
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O VIROPHARMA INC 405 EAGLEVIEW BLVD EXTON PA 19341
Business Address
MILANO VINCENT (Reporting) CIK: 0001187159 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 231164561